{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:31:23Z","timestamp":1791318683993,"version":"4.3.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.biopha.2008.01.010","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T00:29:50Z","timestamp":1206404990000},"page":"667-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET"],"prefix":"10.1016","volume":"62","author":[{"given":"Stefano","family":"Fanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Tomassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Allegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Grassetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2008.01.010_bib1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2008.01.010_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2008.01.010_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/gut.2003.026401","article-title":"Incidence and management of malignant digestive endocrine tumours in a well defined French population","volume":"53","author":"Lepage","year":"2004","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2008.01.010_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000080731","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","author":"Taal","year":"2004","journal-title":"Neuroendocrinology"},{"issue":"12","key":"10.1016\/j.biopha.2008.01.010_bib5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1055\/s-2005-921092","article-title":"Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland","volume":"37","author":"Ueberberg","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.biopha.2008.01.010_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2265.2001.01175.x","article-title":"Immunohistochemical detection of somatostatin receptor types 1\u20135 in medullary carcinoma of the thyroid","volume":"54","author":"Papotti","year":"2001","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1016\/j.biopha.2008.01.010_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s005950200128","article-title":"Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors","volume":"32","author":"Oda","year":"2002","journal-title":"Surg Today"},{"key":"10.1016\/j.biopha.2008.01.010_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1309\/ETJ3-QBUK-13QD-J8FP","article-title":"Neuroendocrine neoplasia","volume":"113","author":"Wick","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.biopha.2008.01.010_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CCO.0b013e3282f1c595","article-title":"Neuroendocrine tumors of the diffuse neuroendocrine system","volume":"20","author":"Gustafsson","year":"2008","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.biopha.2008.01.010_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.beem.2007.01.003","article-title":"Imaging of neuroendocrine tumours (CT\/MR\/US)","volume":"21","author":"Rockall","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.biopha.2008.01.010_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.beem.2006.12.003","article-title":"Nuclear imaging of neuroendocrine tumours","volume":"21","author":"Sundin","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"Suppl. 4","key":"10.1016\/j.biopha.2008.01.010_bib12","first-page":"iv1","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours","volume":"54","author":"Ramage","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2008.01.010_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/eje.0.1510015","article-title":"Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours","volume":"151","author":"Kaltsas","year":"2004","journal-title":"Eur J\u00a0Endocrinol"},{"key":"10.1016\/j.biopha.2008.01.010_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00261-003-0162-3","article-title":"Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS","volume":"29","author":"Kumbasar","year":"2004","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.biopha.2008.01.010_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.2002.tb04422.x","article-title":"The role of PET in localization of neuroendocrine and adrenocortical tumors","volume":"970","author":"Eriksson","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopha.2008.01.010_bib16","first-page":"1455","article-title":"Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?","volume":"47","author":"Montravers","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopha.2008.01.010_bib17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2967\/jnumed.107.041947","article-title":"18F-DOPA PET and PET\/CT","volume":"48","author":"Nanni","year":"2007","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.biopha.2008.01.010_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.biopha.2008.01.010_bib19","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","article-title":"Comparison of (68)Ga-DOTATOC PET and (111)In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours","volume":"34","author":"Buchmann","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopha.2008.01.010_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-540-31203-1_18","article-title":"Receptor PET\/CT imaging of neuroendocrine tumors","volume":"170","author":"Baum","year":"2008","journal-title":"Recent Results Cancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2008.01.010_bib21","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00259-004-1486-0","article-title":"68Ga-labelled DOTA-derivatised peptide ligands","volume":"31","author":"Meyer","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopha.2008.01.010_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002590050197","article-title":"Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumors","volume":"25","author":"Adams","year":"1998","journal-title":"Eur J Nucl Med"},{"issue":"5","key":"10.1016\/j.biopha.2008.01.010_bib23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00259-006-0350-9","article-title":"Neuroendocrine tumour of the mediastinum: fusion of 18F-FDG and 68Ga-DOTATOC PET\/CT datasets demonstrates different degrees of differentiation","volume":"34","author":"von Falck","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.biopha.2008.01.010_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiology.220.2.r01au25373","article-title":"Whole-body 18F-Dopa PET for detection of gastrointestinal carcinoid tumors","volume":"220","author":"Hoegerle","year":"2001","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.biopha.2008.01.010_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MNM.0b013e328182d606","article-title":"Role of 18F-Dopa PET\/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours","volume":"28","author":"Ambrosini","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.biopha.2008.01.010_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopha.2008.01.010_bib27","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","article-title":"DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals","volume":"30","author":"Wild","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopha.2008.01.010_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","article-title":"68Ga-DOTA-NOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5","volume":"32","author":"Wild","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopha.2008.01.010_bib29","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","article-title":"Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma","volume":"25","author":"Timmers","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.biopha.2008.01.010_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1568009053202054","article-title":"The radionuclide molecular imaging and therapy of neuroendocrine tumors","volume":"5","author":"Li","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"issue":"s2","key":"10.1016\/j.biopha.2008.01.010_bib31","first-page":"S192","article-title":"Clinical significance of adrenal uptake with 68Ga-DOTA-octreotate PET imaging","volume":"34","author":"Singh","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.biopha.2008.01.010_bib32","first-page":"610","article-title":"Tumor response and clinical benefit in neuroendocrine tumors after 7.4GBq (90)Y-DOTATOC","volume":"43","author":"Waldherr","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopha.2008.01.010_bib33","first-page":"406","article-title":"Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC","volume":"22","author":"Wehrmann","year":"2007","journal-title":"Cancer Biother Radiopharm"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332208000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332208000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:40:17Z","timestamp":1760092817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332208000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0753332208000279"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2008.01.010","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2008.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}